TP53 and cervical carcinoma: Therefore, resveratrol's demonstrated ability to modulate p53 in other cancer types raises the possibility that it could similarly restore p53 function in HPV‐driven cervical cancer, potentially sensitising cells to chemotherapeutic agents such as carboplatin and cisplatin, thereby enhancing treatment efficacy.